|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Restructuring and other related charges | |||||
| Total operating expenses | |||||
| Other income (expense), net | |||||
| Loss before provision for (benefit from) income taxes | |||||
| Provision for (benefit from) income taxes | |||||
| Net loss | |||||
| Net loss per share attributable to Class A and Class B common stockholders: | |||||
| Net loss per share attributable to Class A and Class B common stockholders, basic | |||||
| Net loss per share attributable to Class A and Class B common stockholders, diluted | |||||
| Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders: | |||||
| Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic | |||||
| Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders: Basic | |||||
| Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, diluted | |||||
| Net unrealized losses on marketable securities | |||||
| Comprehensive loss | |||||
Loading...